Skip to main content
. 2018 Oct 12;25(5):831–842. doi: 10.1093/ibd/izy313

FIGURE 1.

FIGURE 1.

Proposed “safety pyramid” of inflammatory bowel disease medications. These pyramid positions reflect the authors’ views, interpretation of available data, and clinical practice.